Dotmatics News & Media
Dotmatics is advancing the science industry by introducing Luma Agent, an AI co-scientist built on structured scientific data, gaining media coverage on AI's transformative role in drug discovery and environmental solutions, while recently being acquired by Siemens.
Explore how Dotmatics is evolving with the science industry.
- Dotmatics Featured in Lab Manager: Meet Luma Agent, the AI Co-Scientist Built for Real Science
- Dotmatics introduces Luma Agent: the AI co-scientist built on structured scientific data
- NBC News: How AI is Transforming Drug Discovery
- MSN: Why Artificial Intelligence Could Help Save the Planet
- CIO.Inc: Can AI Finally Close the Gap Between Science and Software?
- NBC News Boston: How AI is Transforming Drug Discovery
- KRON TV: AI in Medicine From Research Assistant to Predictive Partner
- ABC News: How AI is Shaping the Future of Drug Discovery
- Siemens completes acquisition of Dotmatics
Related
Data Evolution in Pharma: The Spread of Multimodal
The pharmaceutical industry is shifting from single-mode to multimodal drug discovery, incorporating diverse therapeutic modalities like biologics, gene therapies, and small molecules, but this evolution presents significant challenges in integrating heterogeneous R&D data and technologies, necessitating advanced, compatible platforms to enable efficient collaboration and leverage AI-driven insights for faster, cost-effective drug development.
From Foundational to Aspirational: Dotmatics CEO on the Three Phases of R&D Digital Transformation
Dotmatics CEO outlines the accelerating digital transformation in life sciences R&D driven by exploding data volumes, emphasizing the shift towards AI and machine learning despite unique industry challenges such as lack of standardized interoperability and a fragmented ecosystem, which complicate progress toward a predictive, generative AI-enabled future in drug discovery.
Limitations of Existing Life Science Software—and the Opportunity to Evolve
Existing life science software tools like ELNs, LIMS, and SDMS, while essential for digitizing workflows and managing data, are limited by their siloed, non-real-time, and non-AI-integrated designs, presenting an opportunity to evolve by integrating them into unified, intelligent platforms—such as Dotmatics Luma—that enable connected, workflow-aware, multimodal scientific intelligence with adaptive workflows, real-time data flow, and cross-functional insights without replacing core systems.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Dotmatics Names Michael Swartz as Chief Strategy Officer
Dotmatics has appointed Michael Swartz, a pioneer in digital transformation of life sciences R&D labs and former Senior VP of Enterprise Product Strategy involved in developing the Dotmatics Luma® Scientific Intelligence Platform, as Chief Strategy Officer to lead long-term strategic initiatives enhancing the company's AI-powered scientific software solutions that unify and analyze complex R&D data for improved decision-making.
The Data Lifecycle: From Instrument Integration to Advanced Analysis
The article discusses how Dotmatics Luma™, a comprehensive scientific data platform, addresses the challenges faced by R&D teams in managing and integrating diverse, multimodal scientific data from instruments and various sources to streamline the entire data lifecycle—from ingestion and processing to advanced analysis—thereby enabling faster, AI-ready insights that accelerate innovation and research outcomes.